We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $1.85M
1-Year Est. Return 176.16%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+176.16%
3 Year Est. Return
+511.75%
5 Year Est. Return
+854.95%
10 Year Est. Return
+8,566.11%
AUM
$82.3M
AUM Growth
-$16M
Cap. Flow
+$2.5M
Cap. Flow %
3.04%
Top 10 Hldgs %
95.89%
Holding
22
New
6
Increased
5
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
GARS
Garrison Capital Inc.
GARS
+$1.25M
2
ABDC
Alcentra Capital Corp
ABDC
+$530K
3
BBDC icon
Barings BDC
BBDC
+$445K
4
FSK icon
FS KKR Capital
FSK
+$247K
5
ACRS icon
Aclaris Therapeutics
ACRS
+$190K

Top Sells

Rank Stock Value
1
TMH
Team Health Holdings Inc
TMH
+$335K
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$306K
3
INDP icon
Indaptus Therapeutics
INDP
+$31K

Sector Composition

Rank Sector Weight
1 Healthcare 81.72%
2 Financials 14.06%
3 Miscellaneous 2.03%
4 Real Estate 1.74%
5 Consumer Discretionary 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
1
DELISTED
Strongbridge Biopharma plc.
SBBP
$40M 48.61%
5,514,994
– –
MTEM
2
DELISTED
Molecular Templates, Inc.
MTEM
$10.2M 12.35%
67,586
– –
KALA icon
3
KALA BIO
KALA
$9.81M
$10.1M 12.23%
218
– –
GARS
4
DELISTED
Garrison Capital Inc.
GARS
$8.11M 9.86%
1,000,000
+150,000
+18% +$1.25M
AGRX
5
DELISTED
Agile Therapeutics
AGRX
$4.9M 5.95%
910
– –
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.77M 2.16%
8,945
– –
JBGS
7
JBG SMITH
JBGS
$685M
$1.43M 1.74%
41,170
+5,041
+14% +$166K
IWM icon
8
CALL
iShares Russell 2000 ETF
IWM
$81.2B
$997K 1.21%
+6,540
New +$982K
ONCT
9
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$799K 0.97%
449
– –
SPY icon
10
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$672K 0.82%
2,519
-74,533
-97% -$19.4M
ICMB icon
11
Investcorp Credit Management BDC
ICMB
$12.8M
$574K 0.7%
70,895
+9,036
+15% +$78K
ABDC
12
DELISTED
Alcentra Capital Corp
ABDC
$500K 0.61%
+59,562
New +$530K
ACRS icon
13
Aclaris Therapeutics
ACRS
$908M
$444K 0.54%
17,994
+7,818
+77% +$190K
BBDC icon
14
Barings BDC
BBDC
$944M
$385K 0.47%
+40,580
New +$445K
INDP icon
15
Indaptus Therapeutics
INDP
$163M
$375K 0.46%
32
-2
-6% -$31K
ADNT icon
16
Adient
ADNT
$1.54B
$373K 0.45%
4,737
– –
FSK icon
17
FS KKR Capital
FSK
$3.44B
$226K 0.27%
+7,677
New +$247K
MDGL icon
18
Madrigal Pharmaceuticals
MDGL
$12.5B
$222K 0.27%
+2,418
New +$138K
MRNS
19
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$152K 0.18%
4,661
+611
+15% +$16.5K
CPRX
20
DELISTED
Catalyst Pharmaceutical
CPRX
$129K 0.16%
+33,110
New +$109K
JAZZ icon
21
Jazz Pharmaceuticals
JAZZ
$16B
– –
-1,997
Closed -$306K
TMH
22
DELISTED
Team Health Holdings Inc
TMH
– –
-7,709
Closed -$335K

Similar funds

1IC
1922 Investment Company Houston, Texas $1.89M AUM 15.39% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
HGCK
HPC Germany & Co KG Potsdam, Germany $1.68M AUM 15.3% 1-Year Est. Return
CA
Cohalo Advisory Snoqualmie, Washington $1.65M AUM 11.44% 1-Year Est. Return
CAM
Creekmur Asset Management Morton, Illinois $2.07M AUM
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.3% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $1.56M AUM 25.68% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Caxton Corporation's Q4 2017 Portfolio in Review

As of Q4 2017, Caxton Corporation held 22 positions worth $82.3M, down 16% from $98.2M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Caxton Corporation deployed $2.5M of net new capital in Q4 2017, opening 6 new positions and adding to 5 existing holdings. Its largest new stake was Alcentra Capital Corp: 59,562 shares worth $500K.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 69% a quarter earlier, followed by Financials and Miscellaneous.

On the sell side, the largest reduction was Indaptus Therapeutics, an estimated $31K trimmed.

  • Caxton Corporation's largest Q4 2017 buy was Alcentra Capital Corp: 59,562 shares worth $500K.
  • Caxton Corporation added most to Garrison Capital Inc. in Q4 2017, an estimated $1.25M increase.
  • Caxton Corporation's biggest Q4 2017 reduction was Indaptus Therapeutics, cutting an estimated $31K.
  • Caxton Corporation fully exited Team Health Holdings Inc in Q4 2017, selling an estimated $335K.
  • Caxton Corporation's ten largest holdings make up 96% of its $82.3M portfolio in Q4 2017.
  • Caxton Corporation opened 6 new positions and closed 2 in Q4 2017.
  • Caxton Corporation's portfolio value fell 16% quarter-over-quarter to $82.3M.

Based on Caxton Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.